A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative;Un nouveau cas d'ataxie cérébelleuse à anticorps anti-GAD traité par corticoïdes et initialement séronégatif

Revue de Medecine Interne

Volumn 27, Issue 8, 2006, Pages 616-619

  Birand, B ^a   Cabre, P ^a   Bonnan, M ^a   Olindo, S ^a   Smadja, D ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Anti GAD antibodies; Cerebellar ataxia; Corticosteroids

Indexed keywords

CORTICOSTEROID; GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ARTICLE; ATAXIA; AUTOIMMUNE DISEASE; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CLINICAL FEATURE; COLLAGEN DISEASE; CORTICOSTEROID THERAPY; DISEASE MARKER; DYSARTHRIA; DYSMETRIA; EVIDENCE BASED PRACTICE; FEMALE; GRAVES DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSCILLOPSIA; SERODIAGNOSIS; SYMPTOM; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; ATROPHY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CEREBELLAR ATAXIA; CEREBELLUM; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MAGNETIC RESONANCE IMAGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747046581     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.04.006     Document Type: Article

References (13)

1. Honnorat J., Saiz A., Giometto B., Vincent A., and Brieva L. Cerebellar ataxia with antiglutamic acid decarboxylase antibodies. Arch. Neurol. 58 (2001) 225-230
2. Honnorat J., Trouillas P., Thivolet C., Aguera M., and Belin M.F. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch. Neurol. 52 (1995) 462-468
3. Trouillas P., Takayanagi T., Hallet M., and Currier R.D. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J. Neurol. Sci. 14 (1997) 205-211
4. Dubas F, Letournel F. Syndrome neurologique paranéoplasique. Encycl. Med. Chir. (Elsevier, Paris), Neurologie, 17-162-A-10, 1998, 6p.
5. Muller A.F., Donnelly M.T., Smith C.M., Grundman M.J., Holmes G.K., and Toghill P.J. Neurological complications of celiac disease: a rare but continuing problem. Am. J. Gastroenterol. 91 (1996) 1430-1435
6. Vahedi K., Bouhinik Y., and Matuchansky C. Maladie cœliaque de l'adulte. Gastroenterol. Clin. Biol. 25 (2001) 485-494
7. Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., Davies-Jones G.A., Gibson A., Jarratt J.A., et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352 (1998) 1582-1585
8. Erdo S.L., and Wolff J.R. Gamma-Aminobutyric acid outside the mammalian brain. J. Neurochem. 54 (1990) 363-372
9. Cabre P., Smadja D., Humbel R.L., Merle H., and Vernant J.C. Progressive encephalomyelitis with rigidity, diabetes mellitus, and retinopathy: an anti-GAD syndrome. Eur. J. Neurol. 3 (1996) 98-101
10. Meinck H.M., Faber L., Morgenthaler M., Seissler J., Maile S., Butler M., et al. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J. Neurol. Neurosurg. Psychiatry 71 (2001) 100-103
11. Chattopadhyay S., Ito M., Cooper J.D., Brooks A.I., Curran T.M., Powers J.M., et al. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum. Mol. Genet. 11 (2002) 1421-1431
12. Saiz A., Arpa J., Sagasta A., Casamitjana R., and Zarranz J.J. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late onset insulin-dependent diabetes mellitus and polyendocrine auto-immunity. Neurology 49 (1997) 1026-1030
13. Lauria G., Pareyson D., Giuseppina Pitzolu M., and Bazzigaluppi E. Excellent response to steroid treatment in anti-Gad cerebellar ataxia. Lancet Neurol. 2 (2003) 634-635